271x Filetype PDF File size 2.35 MB Source: psnc.org.uk
www.pwc.co.uk
The value of
community
pharmacy –
detailed report
PSNC
September 2016
The value of community pharmacy
Contents
Key findings ................................................................................................................................................................... i
Glossary ........................................................................................................................................................................ iv
Introduction ................................................................................................................................................................... 7
Context ........................................................................................................................................................................... 7
Report structure ............................................................................................................................................................ 7
Public health ................................................................................................................................................................. 9
Emergency hormonal contraception services ............................................................................................................10
1. Introduction .............................................................................................................................................................10
2. Description of activity .............................................................................................................................................10
3. Contribution of community pharmacy ................................................................................................................... 12
4. Approach to estimating contribution of community pharmacy ........................................................................... 14
5. Key results and sensitivities ................................................................................................................................... 22
Needle and syringe programmes ............................................................................................................................... 26
1. Introduction ............................................................................................................................................................ 26
2. Description of activity ............................................................................................................................................ 26
3. Contribution of community pharmacy .................................................................................................................. 29
4. Approach to estimating contribution of community pharmacy .......................................................................... 30
5. Key results and sensitivities ................................................................................................................................... 40
Supervised consumption services .............................................................................................................................. 47
1. Introduction ............................................................................................................................................................ 47
2. Description of activity ............................................................................................................................................ 47
3. Contribution of community pharmacy .................................................................................................................. 49
4. Approach to estimating contribution of community pharmacy .......................................................................... 50
5. Key results and sensitivities .................................................................................................................................... 61
Self-care support......................................................................................................................................................... 66
Minor ailments advice ................................................................................................................................................ 67
1. Introduction ............................................................................................................................................................ 67
2. Description of activity ............................................................................................................................................ 67
3. Contribution of community pharmacy .................................................................................................................. 68
4. Approach to estimating the contribution of community pharmacy .................................................................... 70
5. Key results and sensitivities ................................................................................................................................... 78
Medicines support ...................................................................................................................................................... 83
The value of community pharmacy
Managing prescribing errors/clarifying prescriptions ............................................................................................. 84
1. Introduction ............................................................................................................................................................ 84
2. Description of service ............................................................................................................................................. 84
3. Contribution of community pharmacy .................................................................................................................. 85
4. Approach to estimating contribution of community pharmacy .......................................................................... 87
5. Key results and sensitivities ................................................................................................................................... 96
Medicines adjustments ............................................................................................................................................ 100
1. Introduction .......................................................................................................................................................... 100
2. Description of activity .......................................................................................................................................... 100
3. Contribution of community pharmacy ................................................................................................................ 102
4. Approach to estimating the contribution of community pharmacy .................................................................. 102
5. Key results and sensitivities ..................................................................................................................................105
Delivering prescriptions ............................................................................................................................................ 107
1. Introduction ........................................................................................................................................................... 107
2. Description of activity ........................................................................................................................................... 107
3. Contribution of community pharmacy ................................................................................................................ 108
4. Approach to estimating contribution of community pharmacy ........................................................................ 109
5. Key results and sensitivities ................................................................................................................................... 111
Managing drug shortages .......................................................................................................................................... 114
1. Introduction ......................................................................................................................................................... 114
2. Description of activity .......................................................................................................................................... 114
3. Contribution of community pharmacy ............................................................................................................... 115
4. Approach to estimating the contribution of community pharmacy .................................................................. 116
5. Key results and sensitivities ................................................................................................................................ 122
Sustaining supply of medicines in emergencies ...................................................................................................... 126
1. Introduction ......................................................................................................................................................... 126
2. Description of activity .......................................................................................................................................... 126
3. Contribution of community pharmacy ............................................................................................................... 129
4. Approach to estimating contribution of community pharmacy ........................................................................ 129
5. Key results and sensitivities ................................................................................................................................ 136
Medicines Use Reviews (MUR) ................................................................................................................................ 141
1. Introduction ........................................................................................................................................................... 141
2. Description of activity ........................................................................................................................................... 141
3. Contribution of community pharmacy ................................................................................................................. 142
4. Approach to estimating contribution of community pharmacy ......................................................................... 142
The value of community pharmacy
5. Conclusions ............................................................................................................................................................ 146
New Medicine Service (NMS) ................................................................................................................................... 147
1. Introduction ........................................................................................................................................................... 147
2. Description of activity ........................................................................................................................................... 147
3. Contribution of community pharmacy ................................................................................................................ 148
4. Approach to estimating contribution of community pharmacy ........................................................................ 148
5. Key results and sensitivities .................................................................................................................................. 149
Appendix 1 – PSNC/PwC Pharmacy survey ............................................................................................................. 151
Introduction ............................................................................................................................................................... 151
Questionnaire ............................................................................................................................................................ 151
Survey results ............................................................................................................................................................. 152
Respondent profile .................................................................................................................................................... 153
Appendix 2 – PSNC/PwC Data collection ................................................................................................................ 156
Introduction ............................................................................................................................................................... 156
Data collection form .................................................................................................................................................. 156
Results of the data collection .................................................................................................................................... 157
Respondent profile .................................................................................................................................................... 158
Appendix 3 - Estimating the volume of locally commissioned services ................................................................. 161
Introduction ............................................................................................................................................................... 161
Approach to estimating the scale of provision ......................................................................................................... 161
Appendix 4 - Valuing time savings ........................................................................................................................... 165
Introduction ............................................................................................................................................................... 165
Average distance and average journey time ............................................................................................................. 165
Average consultation time......................................................................................................................................... 169
Value of time .............................................................................................................................................................. 170
Valuation areas not assessed .................................................................................................................................... 171
Appendix 5 – Valuing wellbeing ............................................................................................................................... 173
Introduction ............................................................................................................................................................... 173
Approach .................................................................................................................................................................... 173
Results ........................................................................................................................................................................ 173
Appendix 6 - Pharmacy staff time and costs ............................................................................................................ 174
Introduction ............................................................................................................................................................... 174
Approach .................................................................................................................................................................... 174
References .................................................................................................................................................................. 176
no reviews yet
Please Login to review.